• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAX3-FOXO1 和 PAX7-FOXO1 旁系同源物的转录和转化特性的差异。

Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs.

机构信息

Université Paris Cité, CNRS, Institut Jacques Monod, F-75013 Paris, France.

Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum University of Bologna, Bologna, Italy.

出版信息

PLoS Genet. 2022 May 23;18(5):e1009782. doi: 10.1371/journal.pgen.1009782. eCollection 2022 May.

DOI:10.1371/journal.pgen.1009782
PMID:35604932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9166405/
Abstract

The hallmarks of the alveolar subclass of rhabdomyosarcoma are chromosomal translocations that generate chimeric PAX3-FOXO1 or PAX7-FOXO1 transcription factors. Overexpression of either PAX-FOXO1s results in related cell transformation in animal models. Yet, in patients the two structural genetic aberrations they derived from are associated with distinct pathological manifestations. To assess the mechanisms underlying these differences, we generated isogenic fibroblast lines expressing either PAX-FOXO1 paralog. Mapping of their genomic recruitment using CUT&Tag revealed that the two chimeric proteins have distinct DNA binding preferences. In addition, PAX7-FOXO1 binding results in greater recruitment of the H3K27ac activation mark than PAX3-FOXO1 binding and is accompanied by greater transcriptional activation of neighbouring genes. These effects are associated with a PAX-FOXO1-specific alteration in the expression of genes regulating cell shape and the cell cycle. Consistently, PAX3-FOXO1 accentuates fibroblast cellular traits associated with contractility and surface adhesion and limits entry into S phase. In contrast, PAX7-FOXO1 drives cells to adopt an amoeboid shape, reduces entry into M phase, and causes increased DNA damage. Altogether, our results argue that the diversity of rhabdomyosarcoma manifestation arises, in part, from the divergence between the genomic occupancy and transcriptional activity of PAX3-FOXO1 and PAX7-FOXO1.

摘要

横纹肌肉瘤肺泡亚型的特征是染色体易位,导致嵌合 PAX3-FOXO1 或 PAX7-FOXO1 转录因子的产生。在动物模型中,过表达任何一种 PAX-FOXO1 都会导致相关的细胞转化。然而,在患者中,它们衍生自的两种结构遗传异常与不同的病理表现相关。为了评估这些差异的潜在机制,我们生成了表达 PAX-FOXO1 同源物的同基因成纤维细胞系。使用 CUT&Tag 对其基因组募集进行映射,揭示了这两种嵌合蛋白具有不同的 DNA 结合偏好。此外,PAX7-FOXO1 结合导致 H3K27ac 激活标记的募集程度大于 PAX3-FOXO1 结合,并且伴随着邻近基因的转录激活增加。这些效应与调节细胞形状和细胞周期的基因的 PAX-FOXO1 特异性表达改变相关。一致地,PAX3-FOXO1 强调与收缩和表面黏附相关的成纤维细胞特征,并限制进入 S 期。相比之下,PAX7-FOXO1 驱动细胞采用阿米巴样形状,减少进入 M 期,并导致 DNA 损伤增加。总的来说,我们的结果表明,横纹肌肉瘤表现的多样性部分源自 PAX3-FOXO1 和 PAX7-FOXO1 的基因组占据和转录活性的分歧。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/9166405/9486036e587c/pgen.1009782.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/9166405/bd175759cc33/pgen.1009782.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/9166405/014d6ce3c93d/pgen.1009782.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/9166405/9486036e587c/pgen.1009782.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/9166405/bd175759cc33/pgen.1009782.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/9166405/014d6ce3c93d/pgen.1009782.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c970/9166405/9486036e587c/pgen.1009782.g003.jpg

相似文献

1
Divergent transcriptional and transforming properties of PAX3-FOXO1 and PAX7-FOXO1 paralogs.PAX3-FOXO1 和 PAX7-FOXO1 旁系同源物的转录和转化特性的差异。
PLoS Genet. 2022 May 23;18(5):e1009782. doi: 10.1371/journal.pgen.1009782. eCollection 2022 May.
2
The PAX-FOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition.PAX-FOXO1s 触发鸡胚神经细胞快速转分化为具有组织侵袭性的肺泡横纹肌肉瘤,其受 S 期进入抑制限制。
PLoS Genet. 2020 Nov 11;16(11):e1009164. doi: 10.1371/journal.pgen.1009164. eCollection 2020 Nov.
3
Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.横纹肌肉瘤中重现的 t(2;2) 和 t(2;8) 易位,而没有典型的 PAX-FOXO1 融合,使 PAX3 与核受体转录共激活因子家族的成员结合。
Genes Chromosomes Cancer. 2010 Mar;49(3):224-36. doi: 10.1002/gcc.20731.
4
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.肺泡横纹肌肉瘤中涉及PAX和FOX家族成员的基因融合。
Oncogene. 2001 Sep 10;20(40):5736-46. doi: 10.1038/sj.onc.1204599.
5
Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group.横纹肌肉瘤中融合基因扩增的基因组和临床分析:来自儿童肿瘤协作组的报告。
Genes Chromosomes Cancer. 2012 Jul;51(7):662-74. doi: 10.1002/gcc.21953. Epub 2012 Mar 23.
6
PAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.肺泡横纹肌肉瘤患儿及青少年的PAX-FOXO1融合状态:对临床、病理及生存特征的影响
Pediatr Blood Cancer. 2023 Apr;70(4):e30228. doi: 10.1002/pbc.30228. Epub 2023 Jan 31.
7
PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization.荧光原位杂交检测老年横纹肌肉瘤患者中 PAX3/7-FOXO1 融合状态。
J Cancer Res Clin Oncol. 2012 Feb;138(2):213-20. doi: 10.1007/s00432-011-1089-7. Epub 2011 Nov 17.
8
[Expression of fusion gene PAX3/PAX7-FKHR and chromosomal aberration in rhabdomyosarcoma].[横纹肌肉瘤中融合基因PAX3/PAX7-FKHR的表达及染色体畸变]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Feb;24(1):42-7.
9
Prognostic value of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma: Systematic review and meta-analysis.PAX3/7-FOXO1融合状态在肺泡横纹肌肉瘤中的预后价值:系统评价与Meta分析
Crit Rev Oncol Hematol. 2015 Oct;96(1):46-53. doi: 10.1016/j.critrevonc.2015.04.012. Epub 2015 May 14.
10
Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature.老年患者头颈部肺泡型横纹肌肉瘤:遗传学特征及文献综述
Hum Pathol. 2009 Mar;40(3):341-8. doi: 10.1016/j.humpath.2008.08.006. Epub 2008 Oct 29.

引用本文的文献

1
Fusion oncogenes in rhabdomyosarcoma: model systems, mechanisms of tumorigenesis, and therapeutic implications.横纹肌肉瘤中的融合致癌基因:模型系统、肿瘤发生机制及治疗意义
Front Oncol. 2025 Jun 17;15:1570070. doi: 10.3389/fonc.2025.1570070. eCollection 2025.
2
First Generation Tools for the Modeling of Capicua (CIC) - Family Fusion Oncoprotein-Driven Cancers.用于Capicua(CIC)家族融合癌蛋白驱动癌症建模的第一代工具。
bioRxiv. 2025 May 14:2025.05.13.653825. doi: 10.1101/2025.05.13.653825.
3
PAX3 Regulatory Signatures and Gene Targets in Melanoma Cells.

本文引用的文献

1
Evidence of pioneer factor activity of an oncogenic fusion transcription factor.致癌融合转录因子的先驱因子活性证据。
iScience. 2021 Jul 16;24(8):102867. doi: 10.1016/j.isci.2021.102867. eCollection 2021 Aug 20.
2
Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies.使用针对断点的单克隆抗体检测肺泡横纹肌肉瘤中 PAX-FOXO1 融合蛋白。
Mod Pathol. 2021 Apr;34(4):748-757. doi: 10.1038/s41379-020-00719-0. Epub 2020 Dec 9.
3
The PAX-FOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition.
黑色素瘤细胞中的PAX3调控特征与基因靶点
Genes (Basel). 2025 May 14;16(5):577. doi: 10.3390/genes16050577.
4
The Role of PAX7 in Breast Cancer Prognosis and Its Mechanistic Involvement in the Wnt/β-Catenin Pathway.PAX7在乳腺癌预后中的作用及其在Wnt/β-连环蛋白通路中的机制参与
J Cell Mol Med. 2025 May;29(10):e70602. doi: 10.1111/jcmm.70602.
5
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target.解析MYC在肉瘤中的作用及其作为有前景治疗靶点的潜力
Int J Mol Sci. 2025 Feb 25;26(5):1973. doi: 10.3390/ijms26051973.
6
Prognostic factors in patients with localized and metastatic alveolar rhabdomyosarcoma. A report from two studies and two registries of the Cooperative Weichteilsarkom Studiengruppe CWS.局限性和转移性肺泡横纹肌肉瘤患者的预后因素。来自合作软组织肉瘤研究组CWS的两项研究和两个登记处的报告。
Cancer Med. 2025 Jan;14(1):e70215. doi: 10.1002/cam4.70215.
7
Large-scale discovery of chromatin dysregulation induced by oncofusions and other protein-coding variants.由致癌融合基因和其他蛋白质编码变异诱导的染色质失调的大规模发现
Nat Biotechnol. 2024 Jul 24. doi: 10.1038/s41587-024-02347-4.
8
Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges.融合驱动型肉瘤的表观遗传决定因素:范例与挑战
Front Cell Dev Biol. 2024 Jun 14;12:1416946. doi: 10.3389/fcell.2024.1416946. eCollection 2024.
9
Biological and therapeutic insights from animal modeling of fusion-driven pediatric soft tissue sarcomas.融合驱动型儿科软组织肉瘤动物模型的生物学和治疗学见解。
Dis Model Mech. 2024 Jun 1;17(6). doi: 10.1242/dmm.050704. Epub 2024 Jun 25.
10
Cut&tag: a powerful epigenetic tool for chromatin profiling.切割标签:一种强大的染色质分析表观遗传工具。
Epigenetics. 2024 Dec;19(1):2293411. doi: 10.1080/15592294.2023.2293411. Epub 2023 Dec 17.
PAX-FOXO1s 触发鸡胚神经细胞快速转分化为具有组织侵袭性的肺泡横纹肌肉瘤,其受 S 期进入抑制限制。
PLoS Genet. 2020 Nov 11;16(11):e1009164. doi: 10.1371/journal.pgen.1009164. eCollection 2020 Nov.
4
The nucleus measures shape changes for cellular proprioception to control dynamic cell behavior.核体会测量细胞本体感受的形状变化,以控制细胞的动态行为。
Science. 2020 Oct 16;370(6514). doi: 10.1126/science.aba2644.
5
Efficient low-cost chromatin profiling with CUT&Tag.利用 CUT&Tag 进行高效、低成本的染色质谱分析。
Nat Protoc. 2020 Oct;15(10):3264-3283. doi: 10.1038/s41596-020-0373-x. Epub 2020 Sep 10.
6
Pioneer Transcription Factors Initiating Gene Network Changes.先驱转录因子引发基因网络变化。
Annu Rev Genet. 2020 Nov 23;54:367-385. doi: 10.1146/annurev-genet-030220-015007. Epub 2020 Sep 4.
7
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma.组蛋白过度乙酰化破坏横纹肌肉瘤的核心基因调控结构。
Nat Genet. 2019 Dec;51(12):1714-1722. doi: 10.1038/s41588-019-0534-4. Epub 2019 Nov 29.
8
JASPAR 2020: update of the open-access database of transcription factor binding profiles.JASPAR 2020:转录因子结合谱开放获取数据库的更新。
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92. doi: 10.1093/nar/gkz1001.
9
The diverse roles of DNA methylation in mammalian development and disease.DNA 甲基化在哺乳动物发育和疾病中的多种作用。
Nat Rev Mol Cell Biol. 2019 Oct;20(10):590-607. doi: 10.1038/s41580-019-0159-6. Epub 2019 Aug 9.
10
Rhabdomyosarcoma.横纹肌肉瘤。
Nat Rev Dis Primers. 2019 Jan 7;5(1):1. doi: 10.1038/s41572-018-0051-2.